We represent the innovative pharmaceutical industry globally, with a focus on three priorities: innovation, equitable access, and ethics. #AlwaysInnovating
Geneva
- Tweets 16,221
- Following 1,216
- Followers 9,159
- Likes 4,483
Investing in innovative medicines and vaccines doesn’t just save lives - it transforms our future. It strengthens health, drives economic growth, and improves health security.
#AlwaysInnovating
6
1
2
2,552
Global health #security remains fragile. The #Ebola outbreak underscores the need for sustained investment in pharmaceutical innovation, stronger health systems, & policy and financing frameworks that make scientific progress possible.
Learn more 👇
ifpma.org/publications/stren…
101
Fostering innovation, strengthening health systems, and effective partnerships must be global priorities for today's global health architecture reform.
Read the op-ed by @DavidReddyIFPMA on @HealthPolicyWatch 👇
healthpolicy-watch.news/the-…
1
119
Adult #immunization is vital for healthy aging. By 2060, adults 55–64 will be 30% of the workforce. Each $1 invested returns up to 19×, while preventable diseases cost G20 economies $1T yearly.
🔗 Learn more:
ifpma.org/publications/adult…
106
🌍 As clinical research becomes increasingly global, greater convergence in clinical trial review processes can make all the difference by reducing delays and helping patients access innovative therapies faster, wherever they are.
📖 Download now:
ifpma.org/publications/consi…
88
1 in 3 people globally live with an NCD. 82% of premature NCD deaths happen in low- and middle-income countries.
140+ initiatives on #GlobalHealthProgress show how partnerships are closing that gap 👇
ifpma.info/4x1dSwt
#AlwaysInnovating #LeadOnNCDs #ActOnNCDs
100
As populations age and #NCDs rise, fewer workers support more with chronic illness.
Adults with #CVD are 10x more likely to suffer a heart attack after flu. NCDs cost the EU ~€437.7B/year in lost productivity.
🔗ifpma.org/publications/inves…
#AlwaysInnovating #LeadOnNCDs #ActOnNCDs
144
#Prevention is one of our most powerful tools against #NCDs.
Adult immunization is cost-effective, slows disease progression, cuts healthcare needs, and helps people stay independent in education or work.
🔗ifpma.info/3SVQaQw
#AlwaysInnovating #LeadOnNCDs #ActOnNCDs
114
Nearly half of NCD deaths link to preventable, interlinked cardiovascular, renal & metabolic (#CVRM) conditions.
Breakthroughs are transforming care for the 30-40% of people living with multimorbidities.
🔗 ifpma.info/4qIDm08
#AlwaysInnovating #LeadOnNCDs #ActOnNCDs
2
1
1
157
Medicines have transformed how the world fights #NCDs. The industry has launched 1,400+ new medicines in the past decade, with 9,600+ more in development.
🔗 Learn more:
ifpma.info/4l6cnHo
#AlwaysInnovating #LeadOnNCDs #ActOnNCDs
3
193
100 days since the #Ebola outbreak was declared in the DRC, IFPMA and @IAmBiotech underline the industry's track record on health emergencies and call for a #PABS system that strengthens industry engagement in pandemic response.
🔗Read the news release:
ifpma.org/news/100-day-miles…
1
173
Preventable diseases cost #G20 economies over USD 1 trillion annually in productivity among people aged 50–64.
Our new infographic with #GCOA explores vaccination as strategic economic infrastructure for productivity, healthy ageing, and preparedness.
bit.ly/3Tukq8S
1
171
#AI and Machine Learning are rapidly transforming pharmaceutical manufacturing.
IFPMA’s new position paper explores how the industry can apply AI in manufacturing and control and offers key considerations for national regulatory authorities.
🔗 ifpma.org/publications/artif…
136
🌎 Global Health Progress is an interactive resource hub spotlighting collaborations between the innovative pharmaceutical industry and global partners to advance the #SDGs.
See the numbers behind the impact:
🔗 globalhealthprogress.org
111
How can data‑driven insights help improve the safety, efficacy, and effectiveness of care worldwide?
IFPMA’s new publication explores how every patient interaction generates information that can advance healthcare when used responsibly.
bit.ly/4gH9GgR
2
163
Routine immunization isn't just a health service, it is core to health security, shaping how fast countries respond when a crisis emerges.
Read more by IFPMA's Laetitia Agostini Bigger in @MediaplanetUK's Global Health Resilience and @guardian campaign:
bit.ly/4ylJwqt
1
1
133
IFPMA’s new publication explores the R&D ecosystem for medicines and vaccines, highlighting the conditions needed to sustain innovation and ensure scientific progress translates into benefits for people, economies, and societies.
ifpma.org/publications/enabl…
1
111
Adult immunization is a high-impact, cost-effective investment in economic growth & societal resilience, yet is underinvested, leaving economies exposed to avoidable costs.
Read more in our position paper:
🔗 ifpma.org/publications/inves…
109
#Prevention, including #immunization and #screening, helps people stay healthier for longer, reducing illness and disability, and boosting productivity. Sustained investment is key to healthy ageing.
Learn more: bit.ly/4ojjJdT
#PreventionForChange
91
The pharma industry is the world's most R&D-intensive sector, supporting millions of jobs and productivity across @G7 economies.
DG @DavidReddyIFPMA discusses innovation as a strategic investment in his op-ed in @GloGovMedia:
bit.ly/4av6CR5
2
139
Since the 1990’s, over 70% of life-expectancy gains in developing and high-income countries are tied to pharmaceutical innovation. Today, there are over 12,000 medicines in clinical development, which could expand healthspan and improve the lives of millions.
#AlwaysInnovating
1
103